Metastatic pancreatic neuroendocrine tumor presenting as a pituitary space occupying lesion: a case report

被引:9
作者
Gur, Chamutal
Lalazar, Gadi
Salmon, Asher [3 ]
Dubiner, Victoria [2 ]
Gross, David J. [1 ]
机构
[1] Hadassah Hebrew Univ, Med Ctr, Endocrinol & Metab Serv, Dept Med, IL-91120 Jerusalem, Israel
[2] Hadassah Hebrew Univ, Med Ctr, Dept Pathol, IL-91120 Jerusalem, Israel
[3] Hadassah Hebrew Univ, Med Ctr, Dept Oncol, IL-91120 Jerusalem, Israel
关键词
neuroendocrine tumor; pituitary; pancreas; metastasis; somatostatin;
D O I
10.1007/s11102-007-0053-7
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Neuroendocrine tumor metastases to the pituitary gland are very rare. There are few case reports of carcinoid tumor metastases to the pituitary, but no cases of pancreatic neuroendocrine pituitary metastases have been reported. In this report we present a 55-year-old female with a sellar mass, ophthalmoplegia and headaches initially thought to represent an invasive null cell pituitary adenoma. However a histological (trans-sphenoidal and liver biopsies) and systemic investigation proved it to be a metastasis of an undiagnosed pancreatic neuroendocrine tumor. Our patient was unique in respect to the location of the metastasis and the uncharacteristically high proliferative index of her tumor. She received conventional therapy consisting of Sandostatin, chemotherapy and radiotherapy as well as labeled somatostatin following an avid uptake on octreotide scanning. Despite a radiological improvement the patient suffered progressive clinical deterioration and died.
引用
收藏
页码:293 / 297
页数:5
相关论文
共 23 条
[1]   Malignant carcinoid tumor of the anterior mediastinum metastasis to a prolactin-secreting pituitary adenoma: A case report [J].
Abe, T ;
Matsumoto, K ;
Iida, M ;
Hayashi, M ;
Sanno, N ;
Osamura, RY .
SURGICAL NEUROLOGY, 1997, 48 (04) :389-394
[2]   Introduction: Definition, historical aspects, classification, staging, prognosis and therapeutic options [J].
Arnold, R .
BEST PRACTICE & RESEARCH CLINICAL GASTROENTEROLOGY, 2005, 19 (04) :491-505
[3]   Somatostatin analogues in the treatment of gastroenteropancreatic neuroendocrine turnors [J].
Delaunoit, T ;
Rubin, J ;
Neczyporenko, F ;
Erlichman, C ;
Hobday, TJ .
MAYO CLINIC PROCEEDINGS, 2005, 80 (04) :502-506
[4]   The doxorubicin-streptozotocin combination for the treatment of advanced well-differentiated pancreatic endocrine carcinoma: a judicious option? [J].
Delaunoit, T ;
Ducreux, M ;
Boige, V ;
Dromain, C ;
Sabourin, JC ;
Duvillard, P ;
Schlumberger, M ;
de Baere, T ;
Rougier, P ;
Ruffie, P ;
Elias, D ;
Lasser, P ;
Baudin, E .
EUROPEAN JOURNAL OF CANCER, 2004, 40 (04) :515-520
[5]  
Fassett Daniel R, 2004, Neurosurg Focus, V16, pE8
[6]   Carcinoid metastasis to the brain [J].
Hlatky, R ;
Suki, D ;
Sawaya, R .
CANCER, 2004, 101 (11) :2605-2613
[7]  
Huang M C, 2001, Zhonghua Yi Xue Za Zhi (Taipei), V64, P414
[8]   Complete histological regression of metastatic carcinoid tumour after treatment with octreotide [J].
Imtiaz, KE ;
Monteith, P ;
Khaleeli, A .
CLINICAL ENDOCRINOLOGY, 2000, 53 (06) :755-758
[9]   Recent advances in radiological and radionuclide imaging and therapy of neuroendocrine tumours [J].
Kaltsas, G ;
Rockall, A ;
Papadogias, D ;
Reznek, R ;
Grossman, AB .
EUROPEAN JOURNAL OF ENDOCRINOLOGY, 2004, 151 (01) :15-27
[10]   The diagnosis and medical management of advanced neuroendocrine tumors [J].
Kaltsas, GA ;
Besser, GM ;
Grossman, AB .
ENDOCRINE REVIEWS, 2004, 25 (03) :458-511